FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic CancerThierry Conroy, Jean‐Baptiste Bachet, Pascal Hammel et al.|New England Journal of Medicine|2018Cited by 2.8k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III TrialMarc Ychou, P. Rougier, Valérie Boige et al.|Journal of Clinical Oncology|2011Cited by 2.1k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203Jean‐Pierre Gérard, Laurent Bedenne, Éric François et al.|Journal of Clinical Oncology|2006Cited by 1.7k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upMichel Ducreux, Dirk Arnold, Caroline Caramella et al.|Annals of Oncology|2015Cited by 1.3k
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trialThierry Conroy, Jean‐Baptiste Bachet, Jean-François Bosset et al.|The Lancet Oncology|2021Cited by 1.3k